Bruce Downey

Bruce Downey was the CEO of Barr Pharmaceuticals, the parent company to Barr Laboratories and Duramed subsidiaries.[1]

Biography

In January 1993, he was appointed president and chief operating officer. He became chairman and CEO in 1994 when Barr's founder Edwin A. Cohen. stepped down. In 2008, Barr Pharmaceuticals was acquired by Teva Pharmaceutical.[2]

Downey was named Ernst & Young Entrepreneur of the Year in 2009.[3]

Downey received a Bachelor's degree with honors from Miami University in Oxford, Ohio.

References

  1. ↑ "Bruce Downey, Generic-Drug Lord". Bloomberg Businessweek (Business Week Online). October 1, 2001. Retrieved 7 September 2010.
  2. ↑ "Teva Coughs Up $7.46B for Barr Reinforcing Its Number One Spot in the Generics Market". Genetic, Engineering & Biotechnology News. July 18, 2008. Retrieved 7 September 2010.
  3. ↑ "Bruce Downey named Ernst & Young Entrepreneur Of The Year 2009 Winner in the Health Sciences category - Ernst & Young - United States". Ernst & Young. Palm Springs: Ernst & Young. 15 November 2009. Retrieved 7 September 2010.


This article is issued from Wikipedia - version of the Friday, February 12, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.